ZADAXIN® 1,6 mg/ml
SC-Ta1-CF-001
Phase 2 small_molecule active
Quick answer
ZADAXIN® 1,6 mg/ml for Cystic Fibrosis is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Cystic Fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active